comprehensive -WSS

comprehensive

author：entertainment 2025-09-02 09:57:07 - browse：23453

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Alzheimer's risk factor APOE4 may be a distinct form of the disease

focus

hotspot

WSS

Getting Alzheimer's drug Leqembi to patients can be a challenge

After traumatic brain injury, life support decisions can use more time

Medicare Advantage 2025 payments will dip, Biden administration says

Orangutan used medicinal plant to treat wound, first time ever seen

Bird flu reported in person exposed to presumably infected cattle

Bird flu in milk supply is likely coming from asymptomatic cows

knowledge

comprehensive

leisure time

The high cost of giving birth even with insurance

Four alarming medical procedures we’re glad history forgot

Hepatitis C has a cure — but many Americans still lack access to it

Close Medicare's dangerous gaps in addiction treatment coverage

Activists slam private health insurers over coverage restrictions

Why rehabilitation engineers need to center patients in their research

Wildfire smoke exposes gaps in outdoor worker protections

Bird flu in dairy cattle: New measures to control spread to humans

State Dept. review finds Biden bears some blame for Afghanistan failures

Drug companies' payments and gifts affect physicians' prescribing

Wikipedia

H5N1 bird flu found in pasteurized milk: what we know

Four alarming medical procedures we’re glad history forgot

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Getting Alzheimer's drug Leqembi to patients can be a challenge

Exact Sciences stock tumbles despite strong cancer detection sales

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

focus

hotspot

Wikipedia

focus